These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 8733870)

  • 41. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thrombotic risk factors and oral contraception.
    Bokarewa MI; Falk G; Sten-Linder M; Egberg N; Blombäck M; Bremme K
    J Lab Clin Med; 1995 Sep; 126(3):294-8. PubMed ID: 7665978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
    Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
    Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B
    Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resistance to activated protein C in women using oral contraceptives.
    Spannagl M; Dick A; Assmann A; Heinemann L; Schramm W
    Semin Thromb Hemost; 1998; 24(5):423-30. PubMed ID: 9834008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of venous thromboembolism in families with inherited thrombophilia.
    Simioni P; Sanson BJ; Prandoni P; Tormene D; Friederich PW; Girolami B; Gavasso S; Huisman MV; Büller HR; Wouter ten Cate J; Girolami A; Prins MH
    Thromb Haemost; 1999 Feb; 81(2):198-202. PubMed ID: 10063991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activated protein C resistance: What have we learned now that the dust has settled?
    Petäjä JM; Griffin JH
    Ann Med; 1997 Dec; 29(6):469-72. PubMed ID: 9562511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis and clinical characteristics of inherited activated protein C resistance.
    Samama MM; Simon D; Horellou MH; Trossaërt M; Elalamy I; Conard J
    Haemostasis; 1996 Oct; 26 Suppl 4():315-30. PubMed ID: 8979137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral contraception and factor V Leiden mutation in relation to localization of deep vein thrombosis.
    Andersen BS; Olsen J
    Thromb Res; 1998 May; 90(4):191-4. PubMed ID: 9692618
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation.
    McColl M; Tait RC; Walker ID; Perry DJ; McCall F; Conkie JA
    Blood Coagul Fibrinolysis; 1996 Oct; 7(7):689-94. PubMed ID: 8958391
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
    Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ
    Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.
    Vandenbroucke JP; Koster T; Briët E; Reitsma PH; Bertina RM; Rosendaal FR
    Lancet; 1994 Nov; 344(8935):1453-7. PubMed ID: 7968118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to activated protein C as pathogenic factor of venous thromboembolism.
    Chrobák L; Dulícek P
    Acta Medica (Hradec Kralove); 1996; 39(2):55-62. PubMed ID: 9108706
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular genetics of venous thromboembolism.
    Dahlbäck B
    Ann Med; 1995 Apr; 27(2):187-92. PubMed ID: 7632412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
    Faioni EM; Razzari C; Martinelli I; Panzeri D; Franchi F; Mannucci PM
    Am J Hematol; 1997 Jun; 55(2):59-64. PubMed ID: 9208999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resistance to activated protein C caused by a factor V gene mutation.
    Zöller B; Dahlbäck B
    Curr Opin Hematol; 1995 Sep; 2(5):358-64. PubMed ID: 9372020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The inherited basis of venous thrombosis.
    Appleby RD; Olds RJ
    Pathology; 1997 Nov; 29(4):341-7. PubMed ID: 9423212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hereditary deficiency of protein C, protein S and antithrombin III.
    Vittore CP; Demos TC
    Can Assoc Radiol J; 1996 Aug; 47(4):251-6. PubMed ID: 8696990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hypercoagulable states.
    Schafer AI
    Ann Intern Med; 1985 Jun; 102(6):814-28. PubMed ID: 3158262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activated protein C resistance and deficiencies of antithrombin III, protein C or protein S and the risk of thromboembolic disease in users of oral contraceptives.
    Winkler UH
    Eur J Contracept Reprod Health Care; 1998 Jun; 3(2):65-74. PubMed ID: 9710709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.